BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 25957414)

  • 41. Identification of Key Genes Affecting Results of Hyperthermia in Osteosarcoma Based on Integrative ChIP-Seq/TargetScan Analysis.
    Shi Y; Yang F; Wei S; Xu G
    Med Sci Monit; 2017 Apr; 23():2042-2048. PubMed ID: 28453502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data.
    Sun H; Yan L; Tu R; Zhang Y; Ma L; Tang W; Li L; Chen W; Zhan C; Zang R
    Gynecol Obstet Invest; 2017; 82(1):30-38. PubMed ID: 26986489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
    Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
    J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma.
    Zhang F; Chen X; Wei K; Liu D; Xu X; Zhang X; Shi H
    Med Sci Monit; 2017 Jan; 23():172-206. PubMed ID: 28081052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
    Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
    Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of upstream regulators for synovial expression signature genes in osteoarthritis.
    Fei Q; Lin J; Meng H; Wang B; Yang Y; Wang Q; Su N; Li J; Li D
    Joint Bone Spine; 2016 Oct; 83(5):545-51. PubMed ID: 26832188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the underlying genes and mechanism of familial hypercholesterolemia through bioinformatics analysis.
    Wang D; Liu B; Xiong T; Yu W; She Q
    BMC Cardiovasc Disord; 2020 Sep; 20(1):419. PubMed ID: 32938406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crucial genes associated with diabetic nephropathy explored by microarray analysis.
    Wang Z; Wang Z; Zhou Z; Ren Y
    BMC Nephrol; 2016 Sep; 17(1):128. PubMed ID: 27613243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene expression profiling of gastric cancer.
    Jiang HB; Yang TJ; Lu P; Ma YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2109-15. PubMed ID: 25070814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microarray based analysis of gene expression patterns in pancreatic neuroendocrine tumors.
    Wang DD; Liu ZW; Han MM; Zhu ZM; Tu YL; Dou CQ; Jin X; Cai SW; Du N
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3367-74. PubMed ID: 26439030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An insight into the key genes and biological functions associated with insulin resistance in adipose tissue with microarray technology.
    Zhang L; Cui Y; Fu F; Li Z; Pan X; Li H; Li L
    Mol Med Rep; 2015 Mar; 11(3):1963-7. PubMed ID: 25385661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
    Liu Z; Lu Y; He Z; Chen L; Lu Y
    Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole-blood gene expression profiling in ankylosing spondylitis identifies novel candidate genes that may contribute to the inflammatory and tissue-destructive disease aspects.
    Chen K; Wei XZ; Zhu XD; Bai YS; Chen Y; Wang CF; Chen ZQ; Li M
    Cell Immunol; 2013; 286(1-2):59-64. PubMed ID: 24326123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microarray and ChIP-seq data analysis revealed changes in p53-mediated transcriptional regulation in Nutlin-3-treated U2OS cells.
    Zhao S; Niu F; Xu CY; Ye L; Bi GB; Chen L; Gong P; Tian G; Nie TH
    Mol Med Rep; 2015 Sep; 12(3):4284-4290. PubMed ID: 26080812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.